ABT$110.283.84%4.08
After Hours: 110.44+0.16 +0.15%
Abbott Laboratories (ABT)
Date: 2026-11-02 16:00O: 106.89H: 110.48L: 106.40C: 110.28Vol: 7.356M
Abbott Laboratories stock is traded at $110.28, with a volume of 7,355,994. It is up +3.84% in the last 24 hours and up +13.11% over the past month. Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Previous Close:
$106.20
Open:
$106.89
24h Volume:
7,355,994
Relative Volume:
0.72
Market Cap:
$190.83B
Revenue:
$46.59B
Net Income/Loss:
$5.41B
P/E Ratio:
35.65
EPS:
$3.09
Net Cash Flow:
$7.38B
1W Performance:
+5.15%
1M Performance:
+13.11%
6M Performance:
+23.27%
1Y Performance:
-10.79%
1-Day Range:
$106.40$110.48
1-Week Range:
$101.54$110.48
52-Week Range:
$81.97$132.03
Abbott Laboratories Stock (ABT) Company Profile
Name
Abbott LaboratoriesSector
HealthcareIndustry
Medical DevicesPhone
(224) 667-6100Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL, USACompare ABT vs MDT, SYK, BSX, EW
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
ABT Abbott Laboratories | $190.83B | $45.13B | $6.28B | $7.38B | $3.09 |
 MDT Medtronic Plc | $127.03B | $37.54B | $5.23B | $6.13B | $3.73 |
 SYK Stryker Corp | $117.68B | $26.30B | $3.62B | $4.57B | $8.63 |
 BSX Boston Scientific Corp | $64.24B | $21.07B | $3.50B | $3.33B | $2.38 |
 EW Edwards Lifesciences Corp | $53.76B | $6.51B | $1.00B | $1.43B | $1.84 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
Abbott Laboratories Stock (ABT) Financials Data
Abbott Laboratories Stock (ABT) Insider Trading
- John A. McCoy, Jr.Sep 02 '26Officer
- Transaction
- Proposed Sale
- Cost
- $109.52
- #Shares
- 27
- Value ($)
- 2,957
- #Shares Total
- 0
- MCCOY JOHN A. JR.Sep 02 '26VICE PRESIDENT AND CONTROLLER
- Transaction
- Sale
- Cost
- $109.54
- #Shares
- 27
- Value ($)
- 2,958
- #Shares Total
- 24,549
- Ford Robert BAug 25 '26CHAIRMAN AND CEO
- Transaction
- Sale
- Cost
- $115.85
- #Shares
- 398,832
- Value ($)
- 46,204,798
- #Shares Total
- 306,461
- Ford Robert BAug 25 '26CHAIRMAN AND CEO
- Transaction
- Option Exercise
- Cost
- $54.02
- #Shares
- 398,832
- Value ($)
- 21,545,946
- #Shares Total
- 705,293
- Robert B. FordAug 25 '26Officer
- Transaction
- Proposed Sale
- Cost
- $115.85
- #Shares
- 398,832
- Value ($)
- 46,204,386
- #Shares Total
- 0
- Morrone Louis H.Aug 11 '26EXECUTIVE VICE PRESIDENT
- Transaction
- Sale
- Cost
- $109.83
- #Shares
- 5,850
- Value ($)
- 642,506
- #Shares Total
- 70,724
- Louis H. MorroneAug 11 '26Officer
- Transaction
- Proposed Sale
- Cost
- $109.83
- #Shares
- 5,850
- Value ($)
- 642,506
- #Shares Total
- 0
- Robert J. AlpernMay 15 '26Retired Director
- Transaction
- Proposed Sale
- Cost
- $85.25
- #Shares
- 7,587
- Value ($)
- 646,791
- #Shares Total
- 0
- Stratton John GMay 07 '26Director
- Transaction
- Buy
- Cost
- $86.82
- #Shares
- 2,000
- Value ($)
- 173,640
- #Shares Total
- 23,319
- STARKS DANIEL JApr 27 '26Director
- Transaction
- Buy
- Cost
- $92.65
- #Shares
- 10,000
- Value ($)
- 926,537
- #Shares Total
- 6,751,103
